PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Norepinephrine”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 523 records · Page 29Linked to original sources

Newly synthesized dopamine as the precursor for norepinephrine synthesis in bovine adrenomedullary chromaffin cells.

The precursor pool of dopamine for norepinephrine synthesis was investigated in cultured bovine adrenomedullary chromaffin cells incubated with [14C]tyrosine. Under conditions where the intracellular [14C]tyrosine specific activity was constant and [14C]dopamine synthesis was maximal, [14C]dopamine and [14C]norepinephrine accumulated over time, and the total intracellular dopamine content more than doubled within 120 min. When [14C]norepinephrine synthesis was calculated at different times based on the specific activity of [14C]dopamine, this rate was approximately equal to the rate of [14C]dopamine synthesis and was, thus, inconsistent with the observed dopamine accumulation. However, the rate of [14C]norepinephrine synthesis based on the [14C]tyrosine specific activity accounted for the dopamine accumulation, an observation suggesting that newly synthesized dopamine, i.e., dopamine with a specific activity equivalent to that of its precursor, [14C]tyrosine, is preferentially utilized for norepinephrine synthesis. Further studies showed that the subcellular distribution of [14C]dopamine was identical to that of norepinephrine and epinephrine and that the accumulated [14C]dopamine could be converted to norepinephrine within the chromaffin vesicle if dopamine uptake was blocked. Taken together, these results suggest that a small intravesicular dopamine pool, rapidly replenished by newly synthesized dopamine, serves as the substrate for dopamine beta-hydroxylase. Several mechanisms to account for this observation are discussed.

Adrenal Medulla↗

Ethanol-induced inhibition of mouse brain adenosine triphosphatase activities: lack of interaction with norepinephrine in vitro.

The in vitro effects of ethanol on C57BL/6J mouse forebrain ATPase activities were investigated in the presence and absence of norepinephrine. Three enzyme activities (Na + K-ATPase, Mg-ATPase, and low affinity Ca-ATPase) were studied in forebrain homogenates using a colorimetric assay. The effect of norepinephrine on ethanol inhibition of Sprague-Dawley rat brain Na + K-ATPase activity was examined in selected experiments for direct comparison with the results obtained using mouse brain. Ethanol (250-2000 mM) inhibited all ATPase activities in a concentration-dependent manner. In each case the IC50 was well beyond what would be a lethal concentration in vivo. Ethanol inhibition of mouse forebrain Na + K-ATPase activity was competitive with regards to K+ ion concentration, but was uncompetitive for inhibition of Mg-ATPase and Ca-ATPase activities. Norepinephrine (0.1 mM) did not sensitize mouse brain Na + K-ATPase activity to ethanol-induced inhibition. In contrast, norepinephrine sensitized rat brain Na + K-ATPase to ethanol inhibition when tested simultaneously with mouse brain under identical conditions. These results cannot be explained by differences in assay conditions and suggest that the interaction between norepinephrine and ethanol inhibition of Na + K-ATPase activity may be species specific. Norepinephrine alone stimulated mouse and rat brain Na + K-ATPase activity when assayed in imidazole buffer, but not when assayed in tris buffer. Furthermore, 0.1 mM norepinephrine slightly antagonized the inhibitory effect of ethanol on mouse brain Mg-ATPase activity, but did not affect ethanol-induced inhibition of Ca-ATPase activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Adenosine Triphosphatases↗

Factors contributing to blood pressure elevation during norepinephrine and phenylephrine infusions in dogs.

To examine the factors contributing to the rise in systemic blood pressure during alpha- and beta-adrenergic stimulation, phenylephrine, an alpha-adrenergic agonist, and norepinephrine, an alpha- and beta-adrenergic agonist, were infused intravenously to anesthetized dogs until mean aortic blood pressure was raised equally by 40-60 mmHg. Changes in preload were estimated by changes in left ventricular end-diastolic pressure or segment length recorded by an ultrasonic technique. By obstructing the inferior vena cava (IVC), the increase in preload could be reduced to control level during phenylephrine and norepinephrine infusions without altering peripheral resistance (mean aortic blood pressure/cardiac output). Normalization of preload reduced the pressure response by 2/3 during phenylephrine infusion and by 1/4 during norepinephrine infusion. However, after beta-adrenergic blockade by propranolol, normalization of preload reduced the pressure response by 2/3 during both phenylephrine and norepinephrine infusions. Thus, during alpha-adrenergic stimulation, the increase in preload is a more important factor than the increase in peripheral resistance. Norepinephrine raised stroke volume by 24 +/- 5%. When the increase in stroke volume was prevented by IVC obstruction, the pressure response to norepinephrine was halved. Thus, during norepinephrine infusion the rise in stroke volume caused by beta-adrenergic stimulation is as important as alpha-adrenergic stimulation for the pressure response.

Adrenergic alpha-Agonists↗

Thermoregulation: effects of environmental temperature on turnover of hypothalamic norepinephrine.

The hypothesis that norepinephrine is a transmitter in the temperature regulating center of the hypothalamus is based on observations of changes in the rectal temperatures of animals after injections of norepinephrine into the hypothalamus. By introducing tritiated norepinephrine as a label into the endogenous norepinephrine stores in the brain and then measuring the disappearance of tritiated norepinephrine from discrete areas, one can monitor the activity of norepinephrine-containing neurons in those areas. In the rat exposed to heat, the turnover of endogenous norepinephrine appears to be increased selectively in the hypothalamus, whereas exposure to cold has no effect.

Animals↗

Effect of changes in blood flow, norepinephrine, and pH on oxygen uptake by resting skeletal muscle.

The purpose of this study was to examine the effects of norepinephrine infusion alone and during alkalosis on oxygen uptake in the dog gastrocnemius-plantaris muscle group under conditions of constant muscle blood flow. The animals were not cold acclimatized. Blood flow was pump controlled, alkalosis was produced by hyperventilation, and norepinephrine was infused intravenously at a rate of 1--1.5 micrograms/kg per minute. Alkalosis had no effect either alone or in combination with changes in blood flow. Similarly, changing blood flow from a low (0.10 +/- 0.02 mL/g muscle per minute (mean +/- SE)) to a high (0.34 +/- 0.04 mL/g muscle per minute) rate did not alter resting oxygen uptake. Norepinphrine caused an average increase of about 30% in resting muscle oxygen uptake which was sustained for the 15-min sampling period during a low flow-norepinephrine infusion and during the low and high blood flow-norepinephrine-alkalosis sampling periods. Norepinephrine infusion during the period of high muscle blood flow without alkalosis resulted in a transient increase followed by a decrease in muscle oxygen uptake. The data demonstrated that infusion of norepinephrine increased skeletal muscle oxygen uptake in "non-cold-acclimatized" dogs at low constant muscle blood flow. Further, without alkalosis, the norepinephrine effect at high flow was transient.

Alkalosis↗

Influence of atrial natriuretic factor on uptake, intracellular distribution, and release of norepinephrine in rat adrenal medulla.

Several studies have demonstrated that atrial natriuretic factor can bind to adrenal medulla cells. Furthermore, atrial natriuretic factor immunoreactivity has been identified in chromaffin cells. The aim of the present work was to investigate atrial natriuretic factor effects on the uptake, intracellular distribution, and release of norepinephrine in the rat adrenal medulla. Results showed that 100 nM atrial natriuretic factor induced a rapid increase of norepinephrine uptake during the first minute of the incubation period. This increase was maintained for up to 60 min. In addition, only neuronal norepinephrine uptake was increased by the natriuretic factor; non-neuronal norepinephrine uptake was unaltered. Atrial natriuretic factor modified the intracellular distribution of the amine store: the granular fraction of norepinephrine increased, while the cytosolic fraction decreased. On the other hand, different concentrations (10, 50, and 100 nM) of the atrial factor decreased spontaneous [3H]norepinephrine output in a concentration-dependent manner. Furthermore, atrial natriuretic factor (10 nM) also reduced high potassium solution evoked secretion of norepinephrine. These results suggest that atrial natriuretic factor modulates sympathetic activity in the rat adrenal medulla. These effects of atrial natriuretic factor may be related to the catecholamine peripheral mechanism involved in the regulation of arterial blood pressure, smooth muscle tone, metabolic activity, etc.

Adrenal Medulla↗

Lack of norepinephrine--neuropeptide Y interactions in the hypothalamic control of cardiovascular regulation in urethane-anesthetized rats.

Noradrenergic input to the hypothalamus is implicated in cardiovascular and behavioral regulation. The hypothalamus also contains high concentrations of neuropeptide Y (NPY), which often is colocalized in noradrenergic neurons. Systemically, NPY has been demonstrated to act synergistically with norepinephrine. Injections of concentrated solutions of NPY into the cerebral ventricles or hypothalamus have been found to alter ingestive behaviours, but the role of NPY in cardiovascular regulation is unknown. The objectives of this study were to determine if NPY injected directly into the hypothalamus elicits cardiovascular responses and (or) if the simultaneous administration of NPY with norepinephrine alters the cardiovascular responses elicited by norepinephrine alone. The hypothalamus of the urethane-anesthetized rat was mapped for heart rate and blood pressure responses to injections of one of the following: saline; NPY (1.9 or 0.6 pmol per injection site); norepinephrine (24, 81, or 243 nmol per injection site); or the combination of norepinephrine plus NPY. Site and drug selection were randomized. Injections of 0.25 microL were at 1.0 microL/min, bilaterally for bilateral structures and unilaterally for midline structures. Norepinephrine routinely elicited dose-dependent increases in blood pressure with latencies of approximately 1 min, which peaked by 3-5 min, accompanied or followed by tachycardia. Saline and NPY injections alone elicited no significant responses in any site. When NPY was injected together with norepinephrine, there were no significant alterations in cardiovascular variables except for attenuation of pressor responses when NPY was injected into the preoptic region and attenuation of tachycardia when NPY was injected into the caudal hypothalamus.(ABSTRACT TRUNCATED AT 250 WORDS)

Anesthesia↗

Norepinephrine-stimulated lipolysis in acute and chronic hypoxemia.

The effects of acute and chronic hypoxemia on norepinephrine-stimulated lipolysis were studied in dogs. Right-to-left shunts were created in experimental dogs to render them chronically hypoxemic (PaO2 37-55 torr). Control animals received sham operations (PaO2 greater than 70 torr). During air ventilation, there was no significant difference in norepinephrine-induced glycerol and free fatty acid (FFA) rises in the control and experimental groups. In control dogs, glycerol and FFA responses to norepinephrine were unaffected by acutely lowering oxygen tensions (PaO2 46-48 torr) to levels found in air-breathing experimental dogs. However, greater acute reductions in oxygen tensions (PaO2 less than 30 torr) in both control and experimental animals resulted in pronounced glycerol and FFA falls from the elevated levels produced by norepinephrine infusions during air ventilation. PaO2 levels less than 30 torr similarly decreased the glycerol and FFA elevations in control animals given phenoxybenzamine and norepinephrine. As with severe hypoxemia, propranolol suppressed glycerol and FFA increases stimulated by norepinephrine. Theophylline did not influence the hypoxemic-induced glycerol and FFA falls. These observations suggest that severity was important in the hypoxemic inhibition of norepinephrine-stimulated lipolysis; the effects of low oxygen breathing were not ameliorated by chronic hypoxemia. A beta-adrenergic receptor abnormality appears to contribute to this inhibition.

Acute Disease↗

Nitric oxide modulates right ventricular flow and oxygen consumption during norepinephrine infusion.

This study was designed to test if nitric oxide (NO) contributes to norepinephrine-induced right coronary vasodilation and if NO blunts the norepinephrine-induced increase in myocardial oxygen consumption (MVO(2)) in the right ventricle. In five anesthetized, open-chest dogs, mean aortic pressure, heart rate, right ventricular rate of pressure development over time (dP/dt), right coronary blood flow, and right ventricular MVO(2) were measured before and during graded intracoronary infusions of norepinephrine in the absence and presence of a NO synthase blocker, N(omega)-nitro-L-arginine methyl ester (L-NAME; 150 microg/min i.c.). During both conditions, right coronary blood flow and right ventricular MVO(2) significantly increased with graded infusions of norepinephrine. L-NAME significantly blunted the coronary hyperemic response to norepinephrine, although L-NAME did not alter the relationship between right ventricular MVO(2) and norepinephrine dose. However, when right ventricular function was indexed by heart rate x right ventricular maximum dP/dt x peak right ventricular systolic pressure, L-NAME significantly increased the oxygen cost of right ventricular function. These results indicate that NO contributes to norepinephrine-induced right coronary vasodilation and improves right ventricular oxygen utilization efficiency.

Animals↗

Digoxin-norepinephrine response and calcium blocker effects in vascular smooth muscle.

The mechanism of potentiation by digoxin of the response of vascular smooth muscle to norepinephrine was investigated in 5-cm intact segments of rabbit carotid artery. Segments were mounted in a chamber and perfused at constant pressure while flow and upstream and downstream pressures were recorded and resistance was calculated. Each vessel was perfused with a submaximal vasoconstricting concentration of norepinephrine (6 x 10(-6)M) alone, in the presence of digoxin (6 x 10(-5)M), and during exposure to both digoxin and one of the following calcium antagonists: lanthanum chloride (5 x 10(-4)M procaine hydrochloride (5 x 10(-3)M), or verapamil (5 x 10(-5)M). Digoxin potentiated the response to norepinephrine alone by 20% (P less than 0.01), to norepinephrine plus lanthanum chloride by 10% (P less than 0.001), and to norepinephrine plus procaine hydrochloride by 17% (P less than 0.001). Digoxin did not potentiate the norepinephrine response in the presence of verapamil. These data suggest that the mechanism of digoxin potentiation of the norepinephrine response in vascular smooth muscle may involve an alteration in a cellular calcium sequestration or release process. The potential cellular sites that may contribute to this phenomenon are discussed.

Animals↗

Metabolism of norepinephrine in vitro by dog pulmonary arterial endothelium.

The importance of endothelial cells in the removal of norepinephrine from synaptic clefts in dog pulmonary artery was studied. Strips of artery cut helically were denuded of endothelium by gently stroking the intimal surface with a wooden applicator stick or were studied with endothelium intact. All strips were prelabeled in L-[3H]norepinephrine (2 X 10(-7) M) and mounted for superfusion. Superfusate was collected continuously before, during, and after electrical stimulation (10 V, 2 ms, 2 Hz). Measurements were made of the amounts of [3H]norepinephrine and its metabolites in superfusate and in tissue. These studies have established that 3,4-dihydroxyphenylglycol is of neuronal origin and O-methylated metabolites are of extraneuronal origin. The formation of extraneuronal metabolites in smooth muscle and endothelium was examined by either blocking uptake of norepinephrine into each, in turn, or by combining blockade of uptakes with the elimination of access of norepinephrine to endothelial tissue by completely removing it. Electrical stimulation elicited the overflow of large amounts of norepinephrine, 3,4-dihydroxyphenylglycol, and O-methylated metabolites into superfusate in strips with intact endothelium; in strips denuded of endothelium there were striking decreases in the amounts of O-methylated metabolites produced. These studies show that pulmonary arterial endothelium participates in the extraneuronal metabolism of norepinephrine released by sympathetic nerve stimulation.

Animals↗

In vivo monitoring of myocardial interstitial norepinephrine by dialysis technique.

To estimate local sympathetic nerve activity of the heart in vivo, we applied a dialysis technique to the heart and attempted to monitor norepinephrine levels in local myocardial interstitial fluid. The dialysis probe consisted of an 18 x 0.31 mm dialysis fiber with a 50,000-mol wt cutoff. When the probe was perfused at 5 microliters/min in vitro, the average relative recovery rate of norepinephrine was 31.3 +/- 0.6%. Dialysis probes were implanted in the left ventricular lateral wall of the beating heart in anesthetized cats and perfused with Ringer solution at 5 microliters/min. Dialysate norepinephrine concentration was measured using high-performance liquid chromatography with electrochemical detection. 1) After probe implantation, dialysate norepinephrine concentration decreased over the first 120 min and then reached an almost steady level (41.1 +/- 4.7 pg/ml). 2) Electrical stimulation of the left stellate ganglion increased dialysate norepinephrine concentration significantly, from control level of 39.0 +/- 5.8 to 82.0 +/- 7.7 pg/ml (P less than 0.01). After stimulation, dialysate norepinephrine concentration returned to the prestimulation level. The dialysis technique using high-performance liquid chromatography permits monitoring of norepinephrine levels in local myocardial interstitial fluid and detection of changes in local cardiac sympathetic nerve activity in vivo.

Analysis of Variance↗

Different desipramine-sensitive pulmonary removals of plasma epinephrine and norepinephrine in dogs.

The lungs are an important site for the clearance of norepinephrine from the circulation, but the mechanism of removal and its importance for clearance of epinephrine require clarification. In the present study, 3H-labeled epinephrine and norepinephrine were infused intravenously into anesthetized dogs, and blood samples were taken from the pulmonary artery and aorta to compare pulmonary extractions of both catecholamines before and after administration of the neuronal uptake blocking drug, desipramine. Circulating [3H]norepinephrine and [3H]-epinephrine were both extracted by the lungs, but fractional extraction of [3H]epinephrine (8.1 +/- 1.1%) was half that of [3H]norepinephrine (16.9 +/- 1.9%). Pulmonary extractions of both catecholamines were completely blocked by desipramine. Desipramine-sensitive removal accounted for a tenth of the total body extraction of [3H]epinephrine and a third that of [3H]norepinephrine. Pulmonary removal of [3H]epinephrine was 14% that of the total body clearance, whereas pulmonary removal of [3H]norepinephrine was 25% that of the total body clearance. The study showed the following: removal of catecholamines by the canine lung in vivo is by desipramine-sensitive uptake; uptake is half as efficient for epinephrine as norepinephrine: and, pulmonary removal contributes importantly to the desipramine-sensitive component of total body catecholamine clearance.

Animals↗

Modification of training-induced responses by repeated norepinephrine injections in rats.

Rats were subjected to daily (5 times/wk) running exercises, norepinephrine injections (0.5 mg/kg sc), or both for 9 wk; one rat group served as the control. Norepinephrine injections were used to potentiate the effect of the endogenous amine, the release of which is known to be stimulated by exercise. Changes observable in all treated rat groups included reduced weight gain, reduced food intake, decreased amount of epididymal fat, hypertrophy of the heart and adrenals, and increased tail skin temperature response to isoproterenol (0.2 mg/kg sc). The training-specific changes (increased activity of oxidative muscle enzymes) were not potentiated by training under the influence of exogenous norepinephrine administration. The changes produced by repeated norepinephrine injections alone (hypertrophy of the brown adipose tissue and increased colonic temperature response to isoproterenol) failed to develop if the rats underwent physical training in addition to drug treatment. Lower tail skin temperature in a cool environment (15 degrees C) was associated with norepinephrine treatment, whether or not there was simultaneous training. These results suggest that the chronic norepinephrine treatment-physical training combination led to complex adaptive changes that could not be systematically associated with either norepinephrine treatment or physical training alone.

Adipose Tissue, Brown↗

Influence of voluntary exercise on hypothalamic norepinephrine.

We combined hypothalamic tissue and plasma determinations of norepinephrine, dihydroxyphenylalanine, and dihydroxyphenylglycol with measurements of abdominal fat in voluntary running rats to examine the relationship among exercise training, hypothalamic and sympathetic nervous function, and body fat stores. The hypothalamic concentrations of norepinephrine, dihydroxyphenylalanine, and dihydroxyphenylglycol were reduced after exercise training (P < 0.01), with the amount of norepinephrine being strongly associated with the plasma norepinephrine (r = 0.58, P < 0.05) and dihydroxyphenylglycol (r = 0.65, P = 0.01) concentrations. Exercise training resulted in a diminution in abdominal fat mass (P < 0.01). A strong relationship existed between fat mass and hypothalamic norepinephrine content (r = 0.83, P < 0.001). The presence of a positive relationship between the arterial and hypothalamic norepinephrine levels provides presumptive evidence of an association between noradrenergic neuronal activity of the hypothalamus and sympathetic nervous function. The observation that abdominal fat mass is linked with norepinephrine in the hypothalamus raises the possibility that alterations in body fat stores provide an afferent signal linking hypothalamic function and the activity of the sympathetic nervous system.

Abdomen↗

Effects of Ba(2+) on norepinephrine-induced contraction of rat thoracic aorta in vitro.

The aim of this study was to examine the effect of exogenously applied BaCl(2) on the norepinephrine-induced contraction of the rat thoracic aorta. Exogenously applied BaCl(2) (0.3-1 mmol/l) slightly elevated the norepinephrine-induced sustained contraction of the rat thoracic aorta in the absence of nicardipine (1 micromol/l). In the aortic preparation pretreated with nicardipine (1 micromol/l), exogenous BaCl(2) (0.1-3 mmol/l) did not elevate the norepinephrine-induced sustained contraction, but the high concentration of BaCl(2) (10 mmol/l) slightly inhibited the norepinephrine-induced tone. In a Ca(2+)-free Krebs bi- carbonate solution (KBS) containing norepinephrine (1 micromol/l) or a Ca(2+)-free K(+)-rich (60 mmol/l) KBS, exogenously applied BaCl(2) (1-30 mmol/l) caused a sustained contraction of the rat thoracic aorta, and this sustained contraction was completely inhibited by nicardipine (1 micromol/l). Exogenous CaCl(2) (0.1-3 mmol/l) also caused a sustained contraction of the aortic preparation in a Ca(2+)- free KBS containing norephinephrine (1 micromol/l), but such a sustained contraction was partly inhibited by nicardipine (3 micromol/l). These results indicate that Ba(2+) elevates the norepinephrine-induced tone of the rat isolated thoracic aorta by permeating voltage-dependent Ca(2+) channels in the absence of nicardipine, but that Ba(2+) has a minor modification on the norepinephrine-induced sustained contraction of the nicardipine-pretreated preparation.

Animals↗

Influence of magnesium on norepinephrine-and histamine-induced contractions of pulmonary vascular smooth muscle.

We examined the effects of magnesium on contractile responses of the rabbit pulmonary artery. The contractile force was determined, after applications of norepinephrine or histamine, in a normal or Ca++-free solution containing 0 mM Mg++ or 1.2 mM Mg++. In a normal solution, Mg++ increased the EC50 value for histamine, but did not alter the EC50 value for norepinephrine or the maximum force induced by norepinephrine or histamine. Contractile responses to norepinephrine and histamine were equally reduced by a Ca++-free, Mg++-free solution, and were further reduced by a Ca++-free solution containing Mg++, but with a greater reduction in the response to histamine than in the response to norepinephrine. The results indicate that in the pulmonary artery, Mg++ alters the sensitivity to histamine but not to norepinephrine, and may differentially inhibit bound Ca++ release by norepinephrine and histamine.

Animals↗

Role of calcium in different layers of vascular smooth muscle in norepinephrine contraction.

The role of calcium present in adventitial and media-intimal layers of rabbit aorta in the fast (F-) and the slow (S-) components of norepinephrine (10(-5) M) contraction was evaluated in this study. An increased sensitivity and decreased maximum tension to response to norepinephrine was observed in adventitia-free aorta as compared to whole aorta. Incubation in calcium-free Ringer solution with or without EDTA decreased the F-component of norepinephrine contraction of the adventitia-free aorta, whereas the F-component of the whole aorta was not affected. The S-component of both preparations was abolished in calcium-free Ringer solution. Norepinephrine increased calcium uptake into whole and adventitia-free aortic strips. An increase in calcium uptake induced by norepinephrine during the F-component of norepinephrine contraction was also observed. 45Ca efflux studies revealed the presence of an exchangeable calcium fraction in the adventitial layer. These data suggest that F-component of norepinephrine contraction is partially dependent on the extracellular calcium distributed in the adventitial layer of rabbit aorta.

Animals↗